APA (7th ed.) Citation

Toshiya Endo, Takashi Takeuchi, & Shunsuke Maehara. (2020). Pharmacological characterization of a novel, potent, selective, and orally active fatty acid amide hydrolase inhibitor, PKM‐833 [(R)‐N‐(pyridazin‐3‐yl)‐4‐(7‐(trifluoromethyl)chroman‐4‐yl)piperazine‐1‐carboxamide] in rats: Potential for the treatment of inflammatory pain. Wiley.

Chicago Style (17th ed.) Citation

Toshiya Endo, Takashi Takeuchi, and Shunsuke Maehara. Pharmacological Characterization of a Novel, Potent, Selective, and Orally Active Fatty Acid Amide Hydrolase Inhibitor, PKM‐833 [(R)‐N‐(pyridazin‐3‐yl)‐4‐(7‐(trifluoromethyl)chroman‐4‐yl)piperazine‐1‐carboxamide] in Rats: Potential for the Treatment of Inflammatory Pain. Wiley, 2020.

MLA (9th ed.) Citation

Toshiya Endo, et al. Pharmacological Characterization of a Novel, Potent, Selective, and Orally Active Fatty Acid Amide Hydrolase Inhibitor, PKM‐833 [(R)‐N‐(pyridazin‐3‐yl)‐4‐(7‐(trifluoromethyl)chroman‐4‐yl)piperazine‐1‐carboxamide] in Rats: Potential for the Treatment of Inflammatory Pain. Wiley, 2020.